12 Health Care Stocks Moving In Wednesday's After-Market Session
Portfolio Pulse from Benzinga Insights
Healthcare stocks showed significant movement in Wednesday's after-market session. Gainers included Modular Medical (MODD), Atreca (BCEL), Pieris Pharmaceuticals (PIRS), DarioHealth (DRIO), PAVmed (PAVM), and AIM ImmunoTech (AIM). Losers included Vivos Therapeutics (VVOS), Alpha Tau Medical (DRTS), Bio-Path Hldgs (BPTH), Novo Integrated Sciences (NVOS), Alaunos Therapeutics (TCRT), and MSP Recovery (LIFW).
August 16, 2023 | 9:32 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bio-Path Hldgs' stock declined by 8.98% to $0.37. The company's Q2 earnings came out yesterday.
The decline in Bio-Path Hldgs' stock could be a result of the recent release of Q2 earnings.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Alpha Tau Medical's shares declined by 9.34% to $3.4.
The decline in Alpha Tau Medical's shares could be due to market dynamics.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
MSP Recovery's shares decreased by 7.16% to $0.12.
The decrease in MSP Recovery's shares could be due to market dynamics.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Novo Integrated Sciences' stock fell 8.34% to $0.17.
The decline in Novo Integrated Sciences' stock could be due to market dynamics.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Alaunos Therapeutics' stock decreased by 7.23% to $0.14. The company's Q2 earnings came out 2 days ago.
The decrease in Alaunos Therapeutics' stock could be a result of the recent release of Q2 earnings.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Vivos Therapeutics' stock declined by 9.7% to $0.31. The company's Q2 earnings came out today.
The decline in Vivos Therapeutics' stock could be a result of the recent release of Q2 earnings.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
AIM ImmunoTech's shares moved upwards by 7.54% to $0.67. The company's Q2 earnings came out yesterday.
The increase in AIM ImmunoTech's shares could be a result of the recent release of Q2 earnings.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Atreca's shares increased by 9.97% to $0.43. The company's Q2 earnings report came out 4 days ago.
The increase in Atreca's shares could be a result of the recent release of Q2 earnings.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
DarioHealth's stock increased by 7.92% to $2.86. The company's Q2 earnings came out 4 days ago.
The increase in DarioHealth's stock could be a result of the recent release of Q2 earnings.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Modular Medical's stock rose 33.3% to $1.36 during Wednesday's after-market session. The company's Q1 earnings came out 2 days ago.
The significant increase in the stock price could be attributed to the recent release of Q1 earnings.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
PAVmed's stock increased by 7.91% to $0.27. The company's Q2 earnings came out yesterday.
The increase in PAVmed's stock could be a result of the recent release of Q2 earnings.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Pieris Pharmaceuticals' shares increased by 8.06% to $0.26.
The increase in Pieris Pharmaceuticals' shares could be due to market dynamics.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100